Vytrus Biotech (XMAD:VYT) Insider Ownership: 0.00 % (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:VYT Vytrus Biotech SA XMAD:VYT
69 GF Score
Price €17.00
GF Value €5.75
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Vytrus Biotech Insider Ownership?

Vytrus Biotech XMAD:VYT 69 Insider Ownership is 0.00 % as of Sep. 22, 2026. GuruFocus rates XMAD:VYT with a GF Score™ of 69/100 and a GF Value™ of €5.75 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vytrus Biotech's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vytrus Biotech's Institutional Ownership is 0.90%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vytrus Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.

Vytrus Biotech Insider Ownership Historical Data

* Premium members only.

The historical data trend for Vytrus Biotech's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech Insider Ownership Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Insider Ownership
Get a 7-Day Free Trial - - - - -

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
XMAD:VYT
69GF Score
Vytrus Biotech SA XMAD:VYT
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vytrus Biotech Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
Vytrus Biotech (XMAD:VYT) has a Insider Ownership of 0.00 % as of Sep. 22, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Vytrus Biotech and its competitors.
Is Vytrus Biotech's Insider Ownership too high?
Vytrus Biotech's current Insider Ownership is 0.00 %. Overall, Vytrus Biotech has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vytrus Biotech's Insider Ownership compare to VRTX and REGN?
Vytrus Biotech's Insider Ownership of 0.00 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Vytrus Biotech and its competitors. Vytrus Biotech's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vytrus Biotech stock overvalued right now?
Based on GuruFocus' analysis, Vytrus Biotech (XMAD:VYT) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.75, compared to a current price of €17.00 — trading 195.7% above its estimated fair value. The current Insider Ownership is 0.00 %. Vytrus Biotech's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Vytrus Biotech (XMAD:VYT), the current Insider Ownership is 0.00 % as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vytrus Biotech (XMAD:VYT) Overvalued in 2026?

Based on GuruFocus' analysis, Vytrus Biotech stock appears to be overvalued. The current stock price of €17.00 is trading 195.7% above its estimated GF Value™ of €5.75. GuruFocus considers Vytrus Biotech to be Significantly Overvalued.

Key valuation signals for XMAD:VYT:

  • Insider Ownership: 0.00 %
  • GF Value™: €5.75 vs. price of €17.00 (195.7% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the XMAD:VYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vytrus Biotech Business Description

Other Exchanges V5P:Germany
Address Sant Gaieta 121, 2nd Floor, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA is a Spanish biotechnology company that develops, manufactures, and sells natural active ingredients for the cosmetic and personal care industry. Using plant stem cell technology and sustainable biotechnological processes, it produces proprietary bioactive compounds derived from plant sources. Its product portfolio includes ingredients marketed under names such as Capilia Longa, Olea Vitae, Nectaria Lithops, Qura Noni, and Turmeric Zen, which are positioned for applications including anti-aging, hair care, skin brightening, and soothing. The company sells primarily to cosmetic ingredient distributors, formulators, and beauty brands rather than to end consumers, generating revenue through the sale of these specialty actives. Vytrus Biotech is headquartered in Terrassa, Spain, and serves customers in international markets across Europe, the Americas, and Asia, with a significant share of sales generated outside its home country.
69GF Score

Get the complete analysis for XMAD:VYT

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.00
Price
€5.75
GF Value